Published in Gastroenterology Week, December 26th, 2005
In a recent article published in the journal BMC Cancer, scientists in Australia detailed a study conducted "to prospectively evaluate the efficacy and safety of SIR spheres in patients with inoperable liver metastases from colorectal cancer who have failed 5-FU based chemotherapy. Patients were prospectively enrolled at three Australian centers. All patients had previously received 5-FU based chemotherapy for metastatic colorectal cancer."
"Patients were ECOG 0-2 and had liver dominant or liver only...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.